How would you approach the treatment of patients with von Willebrand disease or hemophilia A previously managed with intranasal DDAVP during the recall?

Topics: Pediatric Oncology • Medical Oncology • Hematology • Benign Hematology • Hemophilia

During the Stimate recall, how are we performing DDAVP challenges for newly diagnosed hemophilia A or von Willebrand disease?

Answer from: at Community Practice

There are two separate questions here, one is easy and one complicated. Desmopressin challenges can be performed with intravenous desmopressin, 0.3 mcg/kg. It is not necessary to challenge a patient with IV who previously responded well to the nasal preparation, in my view. &nb...

Comments

at Kidz Medical Services, Inc
I would add another consideration which is to re-e...

Related Questions